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Synopsis
KSHV (Kaposi’s sarcoma-associated herpesvirus), or HHV-8 (human herpesvirus 8), is associated with the
pathogenesis of KS, the most common AIDS-related malignancy. xCT (functional subunit of the cystine/
glutamate transporter xc
− system) is known as the HHV-8 fusion-entry receptor as well as an oncogenic protein.
How the xCT triggers the signal transduction of HHV-8 infection and the cell proliferation remains incomplete. We
found that xCT was overexpressed in KS tissues and HHV-8-positive BCBL-1 cells. When xCT cDNA plasmids were
transfected into the HHV-8-negative BJAB cells, the expression of 14-3-3β and cell growth rate were increased. In
contrast, the expression of 14-3-3β and the cell growth rate of HHV-8-positive BCBL-1 cells were suppressed by
either xCT siRNA (short interfering RNA) or an xCT inhibitor, sulfsalazine. These results suggest that 14-3-3β is a
downstream effector of xCT in KS to mediate the cell proliferation.
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INTRODUCTION
KS (Kaposi’s sarcoma) was ﬁrst described by a Hungarian der-
matologist, Moritz Kaposi, in 1872. It grows slowly and exhibits
lesions on skin or internal organs. Skin lesions are the major
symptoms of most KS patients [1]. KS is categorized into four
types: CKS (classic KS), AIDS-KS (AIDS-associated KS), en-
demicKSandimmunosuppression-associatedortransplantation-
associated KS [2]. The frequency of KS differs in regions and
in populations. It occurs mostly in Jews and people of Medi-
terranean origin [3]. In China, Xinjiang is the region with the
highest incidence of KS [4]. CKS has been reported mainly
in Uygur and Kazakh populations in Xinjiang. In 1994, Chang
et al. [5] identiﬁed DNA fragments of a previously unrecognized
herpesvirus in a KS patient with AIDS, which was called KSHV
(Kaposi’ssarcoma-associatedherpesvirus;alsoknownasHHV-8
(human herpesvirus 8).KSHV has now been detected inall kinds
of KS. HHV-8 is regarded as an important causative agent of KS.
Currently, the knowledge about the pathogenesis of KS is quite
limited due to the complexity of signalling pathways for HHV-8
infection and KS formation.
............................................................................................................................................................................................................................................................................................................
Abbreviations used: GAPDH, glyceraldehyde-3-phosphate dehydrogenase; KS, Kaposi’s sarcoma; AIDS-KS, AIDS-associated KS; CKS, classic KS; FBS, fetal bovine serum; HHV-8,
human herpesvirus 8; KSHV, Kaposi’s sarcoma-associated herpesvirus; MAPK, mitogen-activated protein kinase; MAPKK, MAPK kinase; MEK1, MAPK/ERK
(extracellular-signal-regulated kinase) 1; RT–PCR, reverse transcription–PCR; SASP , sulfasalazine; siRNA, short interfering RNA; SLC7A11, solute carrier family 7 member 11; YWHAB,
tyrosine 3-mono-oxygenase/tryptophan 5-mono-oxygenase activation protein, beta polypeptide; xCT, functional subunit of the cystine/glutamate transporter xc
− system.
1Correspondence may be addressed to either of these authors (email wli@genetics.ac.cn or yanglei62@yahoo.com).
The 14-3-3 family is a highly conserved, ubiquitously ex-
pressed protein family [6–8]. In mammals, there are at least
seven isoforms: β, γ, ε, η, σ, ζ and τ. 14-3-3 proteins are in-
volved in multiple processes including cell growth, survival and
differentiation. 14-3-3 regulates cell growth through its interac-
tion with Raf-1. In the MAPK (mitogen-activated protein kinase)
signallingcascade,Raf-l[MAP3K(MAPKkinasekinase)]activ-
ates MEK1 [MAPK/ERK (extracellular-signal-regulated kinase)
1] and MEK2 [also known as MAPKK (MAPK kinase),
orERKactivatorkinase].ERKisactivatedbyMEK1andMEK2.
ERK in turn activates downstream MAPK to regulate gene ex-
pression [9]. In our previous studies, we found that 14-3-3β
[encoded by YWHAB (tyrosine 3-mono-oxygenase/tryptophan 5-
mono-oxygenase activation protein, beta polypeptide)] is highly
expressed in the KS tumour tissues compared with adjacent nor-
mal tissues from KS patients [10]. This suggests that 14-3-3β
may play a role in the tumorigenesis of KS. However, the
14-3-3β upstream signalling pathway remains incomplete.
System xc–, consisting of a catalytic light chain xCT (func-
tionalsubunitofthecystine/glutamatetransporterxc
− system)[or
SLC7A11 (solute carrier family 7 member 11)] and a regulatory
heavy chain (4F2hc), transports cystine into cells in exchange for
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the release of glutamate at a 1:1 ratio. Within the cell, cystine is
rapidly reduced to cysteine, the rate-limiting substrate for gluta-
thione synthesis. System xc– plays an important role in antiox-
idation by regulating the intracellular glutathione level [11,12].
Cystine uptake in human cancer cells is mainly dependent on
system xc–. It has been shown that xCT is highly expressed
in multiple cancers such as hepatoma, lymphoma, glioma and
lung, colon, breast, prostate and pancreatic cancer cells, which
renders xCT a potential drug target for cancer therapy [13]. Pre-
viously, it has been reported that xCT is the HHV-8 fusion-entry
receptor [14]. HHV-8 induces ERK1/2 to modulate the initiation
of viral gene expression and host cell gene expression [15]. Thus
it is plausible to postulate that HHV-8 entry hijacks the ERK-
mediated MAPK signalling pathway to promote cell prolifera-
tion in KS. Thus xCT may play a dual role in HHV-8-induced KS
formation, as the HHV-8 receptor and as an oncoprotein. We re-
portherethatxCTinduces14-3-3βoverexpressioninKS,forthe
ﬁrsttimeestablishingalinkbetweenxCTandtheERK-mediated
MAPK signalling pathway.
MATERIALS AND METHODS
Tissue samples
Seventeen KS specimens, obtained from 1996 to 2008, were
collected by the Key Laboratory of Xinjiang Endemic and Eth-
nic Diseases in Shihezi University, China. Ten patients with
CKS, four patients with AIDS-KS and three patients with renal
transplantation-associatedKSwereincludedinthepresentstudy.
AllpatientswereHHV-8positive.Skinsamplesof17healthysub-
jects who had plastic surgery were used as a control group. The
present study was approved by the Ethics Committee of Shihezi
University, and all the participants provided written informed
consent. The tumour tissues and tumour-adjacent normal tissues
from KS patients were freshly prepared. Each sample was cut
into two pieces; one was stored in liquid nitrogen for extracting
total RNA and was used for the real-time ﬂuorescent quantitative
PCR tests and the other was ﬁxed in formalin and was embedded
in parafﬁn for immunohistochemistry studies.
Cell lines and cell culture
The melanocyte line from xCT−/− mice (sut) and the mela-a
cell line from wild-type mice (xCT+/+) were established in Dr
Dorothy Bennett’s laboratory (Division of Basic Medical Sci-
ence, St George’s, University of London, London, U.K.) and
cultured as described in [16]. The medium for both xCT+/+ and
xCT−/− melanocytes was supplemented with 2-mercaptoethanol
(Sigma–Aldrich, St. Louis, MO, U.S.A.) [17]. Human BCBL-
1 and BJAB cell lines were kindly provided by Wuhan Insti-
tute of Virology, Chinese Academy of Sciences. These cell lines
weremaintainedinRPMI1640mediumsupplementedwith10%
(v/v) FBS (fetal bovine serum; Sigma–Aldrich). HeLa cells were
grown in Dulbecco’s modiﬁed Eagle’s medium plus 10% FBS.
All cell lines were cultured at 37◦C with 5% CO2.
Real-time ﬂuorescent quantitative PCR
Total RNA was isolated from skin tissues after the removal
of genomic DNA by DNase I treatment and subjected to re-
verse transcription. Real-time ﬂuorescent quantitative PCR was
conducted on 100 ng of cRNA from the 17 KS tissues and
17 KS-adjacent normal tissues. The housekeeping gene GAPDH
(glyceraldehyde-3-phosphate dehydrogenase) was selected for
normalization [18]. An iCycler iQ Real-Time PCR Detection
System(Bio-Rad,Hercules,CA,U.S.A.)wasusedinconjunction
with a QuantiTect SYBR Green RT–PCR kit (Qiagen,Valencia,
CA,U.S.A.)accordingtothemanufacturer’sinstructions.Tocal-
culate the relative expression for each gene, the 2−Ct method
was used as the average Ct (threshold cycle value) value for the
housekeeping gene [19].
Immunohistochemistry
Detection of 5 μm sections of 17 KS tumours was performed
by the immunohistochemical Envision technique. The tissue ar-
ray slide was deparafﬁnized and rehydrated before H2O2 treat-
ment for 30 min at room temperature (25◦C). Antigen retrieval
was performed by microwave heating sections in 10 mmol/l so-
dium citrate buffer (pH 6.0) for 5 min. After blocking of non-
speciﬁc binding, mouse anti-14-3-3β monoclonal antibody (H8,
SC-1657, Santa Cruz Biotechnology) was diluted 1:300 and rab-
bit anti-xCT polyclonal antibody was diluted 1:100, and incub-
ated at 4◦C overnight. Normal human skin tissue sections were
used as controls. Immunostained sections of KS tissues and nor-
mal human skin tissues were scored based on the percentage of
immuno-positive cells (0–100) and staining intensity (0–4).
RNA interference
The speciﬁc siRNA (short interfering RNA; Genechem, Shang-
hai, China) targeted to different regions of SLC7A11 mRNA
were synthesized and tested for efﬁciency in knockdown of
xCT expression [17]. HeLa and BCBL-1 cells were transfec-
ted with siRNAs at 120 pmol each using LipofectamineTM 2000
(Invitrogen, Carlsbad, CA, U.S.A.), with the ﬁnal concentration
of siRNA being 100 nM, and collected for assay at 48 h post-
transfection.
Western blotting
Cell lysates were prepared as described previously [17]. Pro-
tein samples in supernatant (20 μg per lane) were subjected to
SDS/PAGE and transferred on to a PVDF membrane (Millipore,
Bedford, MA, U.S.A.). The PVDF membrane was incubated for
1 h in PBS containing 5% fat-free dried milk, and then incub-
ated with mouse monoclonal antibody to 14-3-3β (1:7000) or
β-actin (1;5000), or rabbit polyclonal antibody to xCT (1:2000)
or ERK1/2 (1:10000) at 4◦C overnight, followed by a 2 h incub-
ation with horseradish peroxidase-conjugated goat anti-mouse
(1:5000) or goat anti-rabbit IgG (1:5000). We prepared the xCT
antiserum immunized with GST (glutathione transferase)–xCT
antigen. All the other antibodies were obtained from Santa Cruz
Biotechnology (Santa Cruz, CA, U.S.A.). Protein bands were
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Figure 1 Higher expression of xCT in KS tissues
(A, C) Real-time ﬂuorescent quantitative PCR detecting SLC7A11 and YWHAB expression in KS and KS-adjacent normal
tissues. SLC7A11 and YWHAB mRNA levels in 17 different KS tissues were normalized to GAPDH and plotted as fold
versus that in KS-adjacent normal tissues of the same patients. Results shown are the means for three independent
experiments. (B, D) Images (magniﬁcation, ×400) of immunohistochemical staining by xCT and 14-3-3β in KS and normal
skin tissues. xCT or 14-3-3β immunoreactivities appear as a homogeneously brown staining in the cytoplasm. In contrast,
the normal control shows negative or weak signals.
detected with ECL® Plus chemiluminescent reagent (GE Health-
care). The intensities of the bands obtained were determined
by an Alpha Imager 2000 densitometer (Alpha Innotech, San
Leandro, CA, U.S.A.). Each densitometric value was expressed
as mean+ −S.D.
Survival rate assay
In the cell survival rate assay, BCBL-1 cells transfected with
SLC7A11 siRNA or control siRNA were seeded on to 96-well
plates at a density of 2×104/cm2 with RPMI 1640 medium
supplemented with 10% FBS for 24 h. Cells were quantiﬁed
by a CCK-8 kit (Dojindo, Kumamoto, Japan). A 10 μl portion
of CCK-8 was added into each well and the attenuance (D)
at 450 nm was measured. Wells with cell medium and CCK-8
solution served as a blank control, whereas wells seeded with
BCBL-1 cells transfected with non-silencing siRNA served as a
negative control. The cell survival rate was calculated as (test–
blank control)/(negative control–blank control)×100%. All ex-
periments were performed in triplicate wells and repeated three
times.
Statistics
Quantitative data in paired groups were analysed using a
Student’s t test. Qualitative data were compared using a χ2 test.
RESULTS
xCT is highly expressed in KS tissues
As xCT may play a dual role (HHV-8 receptor and oncogene)
in HHV-8-induced KS formation, we hypothesize that xCT may
serveasanupstreamcandidatethatisresponsibleforthe14-3-3β
up-regulation in KS. Both SLC7A11 and YWHAB were overex-
pressed in KS tissues by real-time PCR (Figures 1A and 1C) and
immunohistochemical staining (Figures 1B and 1D). Real-time
PCR analyses showed that the SLC7A11 expression in KS tis-
sues was 6.2-fold (on average) higher than that in KS-adjacent
normal tissues (Figure 1A). Likewise, the YWHAB expression
in KS tissues was 9.5-fold (on average) higher than that in KS-
adjacent normal tissues (Figure 1C). xCT has been found to be
..........................................................................................................................................................................................................................................................................................................................................................................
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Figure 2 The expression of 14-3-3β correlates with xCT in different treatments or cell lines
(A) BJAB (HHV-8−) and BCBL-1 (HHV-8+) cells were harvested and total RNA was extracted for semi-quantitative RT–PCR
detection of the expression of SLC7A11 and YWHAB. GAPDH was used as an internal control. (B) Real-time PCR detection
of SLC7A11 and YWHAB mRNA levels in BJAB and BCBL-1 cells. After normalization to GAPDH, SLC7A11 and YWHAB
mRNA expression in BCBL-1 cells was plotted as fold versus the BJAB control. Results shown are the means+ −S.D. for
three independent experiments performed in triplicate (*P<0.01). (C) BJAB and BCBL-1 cells were lysed and subjected
to Western-blot analysis. β-Actin was used as a loading control. (D) Normalized percentages of the band intensities shown
in (C) were calculated. Results shown are the means+ −S.D. for three independent experiments (*P<0.01). (E) BCBL-1
and BCBL-1 cells transfected with SLC7A11 siRNAs (sixCT) were lysed and subjected to Western-blot analysis. β-Actin was
used as a loading control. (F) Normalized percentages of the band intensities shown in (E) were calculated. Results shown
are the means+ −S.D. for three independent experiments (*P<0.01, P<0.05).
up-regulated in a variety of cancer cells [13], and these ﬁnd-
ings ﬁrst revealed that xCT is overexpressed in KS tissues. To
further establish the correlation between xCT and 14-3-3β,w e
overexpressed or down-regulated the xCT activity to see whether
14-3-3β changes accordingly in the following studies.
xCT induces the expression of 14-3-3β
BCBL-1 (HHV-8+) cells promote lymphoma formation in SCID
(severe combined immunodeﬁciency) mice, mimicking the fea-
tures of KS cells [20]. We therefore determined whether 14-3-3β
and xCT are overexpressed in BCBL-1 cells. Indeed, the expres-
sion of 14-3-3β and xCT in BCBL-1 cells was higher than that in
BJAB (HHV-8−) cells (Figures 2A–2D). Real-time quantitative
RT–PCR (reverse transcription–PCR) analyses showed that the
mRNA expression of SLC7A11 and YWHAB in BCBL-1 cells
was 5.4- and 6.5-fold higher than that in BJAB cells respect-
ively (Figure 2B). Western-blot analyses showed that the protein
levelsofxCTand14-3-3βinBCBL-1cellswere3.8-and4.6-fold
higher than that in BJAB cells respectively (Figure 2D). Further-
more, we found that the expression of 14-3-3β was suppressed
when xCT was knocked down in BCBL-1 (HHV-8+) cells by the
transfection of SLC7A11 siRNA (Figures 2E and 2F). SLC7A11
siRNA effectively down-regulated xCT and 14-3-3β expression
in BCBL-1 cells, resulting in 52% reduction in xCT and 39%
reduction in 14-3-3β at protein levels (Figure 2F).
We next measured the effect of disruption of xCT on the cell
growth of the BCBL-1 cells. The survival rate of BCBL-1 cells
transfected with SLC7A11 siRNA or treated with SASP (sulfas-
alazine) was signiﬁcantly lower than that in the control cells.
The survival rate of BCBL-1 cells transfected with SLC7A11
siRNA was 45% lower than that in the cells transfected with
non-silencing siRNA (Figure 3A). Similarly, the survival rate of
BCBL-1 cells treated with 0.25 mM SASP was 53% lower than
that in the untreated cells (Figure 3B). On the other hand, the
survival rate of BJAB cells transfected with SLC7A11 expression
plasmid pCDNA3-HA-hxCT was signiﬁcantly higher than that
in the cells transfected with empty vector. The survival rate of
BJAB cells transfected with xCT expression plasmid pCDNA3-
HA-hxCTwas157%higherthanthatinthecellstransfectedwith
empty vector (Figure 3C). These results are the ﬁrst to establish a
correlation between xCT and 14-3-3β in promoting cell growth.
xCT promotes cell growth through the
14-3-3β-mediated ERK activation pathway
In the MAPK signalling pathway, 14-3-3β regulates cell growth
throughitsinteractionwithRaf-1,whereasRaf-lactivatesMEK1
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Figure 3 Disruption of xCT affects the KS cell growth rates
Survival rates are shown in BCBL-1 cells transfected with SLC7A11 siRNA (sixCT, left), or treated with 0.25 mM SASP
(middle), or in BJAB cells transfected with pCDNA3-HA-hxCT (right). After normalization to the control, the survival rates
are presented as means+ −S.D. for three experiments performed in triplicates (*P<0.01).
Figure 4 The expression of ERK1/2 correlates with 14-3-3β in different treatments
(A) xCT+/+,x C T −/− melanocyte or HeLa cells were treated with SASP , SLC7A11 siRNA (sixCT) or pCDNA3-HA-hxCT. β-Actin
was used as a loading control. (B) Normalized percentages, which are explained in the text, of the band intensities
shown in (A) were calculated and the results shown are the means+ −S.D. for three independent experiments (*P<0.01,
P<0.05).
and MEK2 (also known as MAPKK, or ERK activator kinase).
ERK is in turn activated by MEK1 and MEK2 [9]. To determ-
ine whether the overexpression of xCT triggers the 14-3-3β-
mediated ERK activation, we measured the expression levels
of both 14-3-3β and ERK1/2 after the cells were transfected
with pCDNA3-HA-hxCT plasmids (Figure 4). We found that the
expression levels of both 14-3-3β and ERK1/2 were higher in
the pCDNA3-HA-hxCT-treated HeLa cells or xCT−/− melano-
cytes than those in the untreated cells. Western-blot analyses
showed that the expression levels of 14-3-3β and ERK1/2 in
HeLa cells transfected with pCDNA3-HA-hxCT plasmids were
134 and 178% higher than those in the cells transfected with
empty vector respectively. Likewise, the expression levels of
14-3-3β a n dE R K 1 / 2i nx C T −/− melanocytes transfected with
pCDNA3-HA-hxCT plasmids were 122 and 127% higher than
those in the cells transfected with empty vector respectively.
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Consistently, the expression levels of both 14-3-3β and
ERK1/2 were lower in the HeLa cells treated with either SASP
or SLC7A11 siRNA than that in the untreated cells. The protein
levelsof14-3-3βandERK1/2inHeLacellstreatedwith0.25 mM
SASP were 54 and 59% lower than those in the untreated cells
respectively. SLC7A11 siRNA effectively down-regulated 14-3-
3β and ERK1/2 expression in HeLa cells, resulting in reduc-
tions of 43% in 14-3-3β and 53% in ERK1/2 at the protein
level. Similarly, the expression levels of 14-3-3β and ERK1/2
in xCT−/− melanocytes were reduced to 50 and 36% respect-
i v e l yi nt h ex C T −/− melanocytes compared with the wild-type
xCT+/+ melanocytes. Taken together, these results suggest that
xCT promotes cell proliferation through the 14-3-3β-mediated
ERK activation pathway.
DISCUSSION
xCT has been reported to be highly expressed in a variety of
cancer cells [13]. In the present study, we report for the ﬁrst
time that xCT is overexpressed in KS. As xCT plays a dual role
in mediating HHV-8 entry and cell proliferation, it may be an
upstream key player in KS formation. We found that xCT may
transduce its signal to 14-3-3β to mediate the MAPK signalling
cascade in cell proliferation.
Our previous studies have shown that xCT is involved in mul-
tiple cellular processes including pheomelanin production and
cellproliferation[16],oxidativestressandendoplasmicreticulum
stress[21]andcancercellmetastasis[17].Allthesefunctionsare
related to cystine uptake as well as intracellular redox modula-
tion. Cancer cells consume more cystine and exhibit higher xCT
activity. It is intriguing how this signal is transduced to the 14-3-
3β-mediated MAPK signalling pathway. xCT forms a complex
with 4F2hc (CD98, SLC3A2) to be a functional system xc–. It
has also been shown that 4F2hc binds to β1 integrin and is in-
volved in β1 integrin-mediated signal cascades [22,23]. Both
xCT and 4F2hc are clustered in the lipid rafts, where xCT associ-
ateswithα3β1integrinvia4F2hcandthusleadstotheactivation
of FAK (focal adhesion kinase) and Src, which activates PI3K
(phosphoinositide 3-kinase) and Rho-GTPases, facilitating ERK
activation [24]. This may explain why overexpression of xCT
correlates with the activation of ERK. However, to discover the
exact molecular link between xCT and 14-3-3β requires further
investigation.
The involvement of xCT in cancer cell proliferation and meta-
stasis renders it a promising therapeutic target in cancer therapy
[13]. Pharmacological inhibition of xCT remarkably inhibited
proliferation of multiple cancer cells in vitro and attenuated tu-
mourgrowthinvivo[13,17].Consistently,wehavedemonstrated
here that SASP inhibits the expression of 14-3-3β and ERK1/2
in HeLa cells and inhibits the cell growth in HHV-8-positive
BCBL-1 cells, further supporting its potential as a drug target in
cancer therapy, including KS. Considering the easy accessibility
of xCT by SASP at the plasma membrane and its upstream role
in 14-3-3β and ERK1/2, xCT is regarded as a better therapeutic
target of the ERK-mediated MAPK signalling pathway in cancer
intervention.
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